![Ronald Crystal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Crystal
Grundare på
Xylocor Therapeutics, Inc.
Profil
Ronald G.
Crystal is the founder of GenVec, Inc. (1992), Xylocor Therapeutics, Inc. (2013), and Lexeo Therapeutics, Inc. (2017).
At Xylocor Therapeutics, Inc., he holds the title of Director.
Dr. Crystal is currently the Chairman of Genetic Medicine at Weill Cornell Medical College.
Crystal is also the founder of Annapurna Therapeutics SAS.
Aktiva positioner av Ronald Crystal
| Företag | Position | Start |
|---|---|---|
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Grundare | 2013-01-01 |
Tidigare kända positioner av Ronald Crystal
| Företag | Position | Slut |
|---|---|---|
| GENVEC INC | Grundare | - |
| LEXEO THERAPEUTICS, INC. | Grundare | - |
Annapurna Therapeutics SAS
 Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
82
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
